Inspire Medical Systems, Inc. (INSP)
USD 142.55
(0.44%)
USD 142.55
(0.44%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 24.84 Million USD | 229.7% |
| 2022 | 7.53 Million USD | -69.36% |
| 2021 | 24.59 Million USD | -19.71% |
| 2020 | 30.63 Million USD | 24.92% |
| 2019 | 24.52 Million USD | -1.62% |
| 2018 | 24.92 Million USD | 51.43% |
| 2017 | 16.46 Million USD | 32.95% |
| 2016 | 12.38 Million USD | 0.0% |
| 2015 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 24.5 Million USD | -100.0% |
| 2024 Q2 | 24.51 Million USD | 0.0% |
| 2024 Q3 | 25.21 Million USD | -100.0% |
| 2023 FY | 24.84 Million USD | 229.7% |
| 2023 Q3 | 25.17 Million USD | 14.14% |
| 2023 Q2 | 22.05 Million USD | 206.95% |
| 2023 Q1 | 7.18 Million USD | -4.66% |
| 2023 Q4 | 24.84 Million USD | -1.3% |
| 2022 Q1 | 21.35 Million USD | -13.19% |
| 2022 Q4 | 7.53 Million USD | -4.39% |
| 2022 FY | 7.53 Million USD | -69.36% |
| 2022 Q3 | 7.88 Million USD | -56.26% |
| 2022 Q2 | 18.01 Million USD | -15.61% |
| 2021 Q1 | 30.76 Million USD | 0.43% |
| 2021 FY | 24.59 Million USD | -19.71% |
| 2021 Q4 | 24.59 Million USD | -1.14% |
| 2021 Q3 | 24.87 Million USD | -10.61% |
| 2021 Q2 | 27.83 Million USD | -9.52% |
| 2020 Q4 | 30.63 Million USD | 24.07% |
| 2020 Q1 | 24.57 Million USD | 0.22% |
| 2020 FY | 30.63 Million USD | 24.92% |
| 2020 Q2 | 24.63 Million USD | 0.23% |
| 2020 Q3 | 24.68 Million USD | 0.23% |
| 2019 Q1 | 24.36 Million USD | -2.25% |
| 2019 FY | 24.52 Million USD | -1.62% |
| 2019 Q4 | 24.52 Million USD | 0.22% |
| 2019 Q3 | 24.46 Million USD | 0.22% |
| 2019 Q2 | 24.41 Million USD | 0.21% |
| 2018 Q3 | 24.81 Million USD | 12.92% |
| 2018 FY | 24.92 Million USD | 51.43% |
| 2018 Q2 | 21.97 Million USD | -8.02% |
| 2018 Q1 | 23.89 Million USD | 45.14% |
| 2018 Q4 | 24.92 Million USD | 0.45% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q4 | 16.46 Million USD | 0.0% |
| 2017 FY | 16.46 Million USD | 32.95% |
| 2016 FY | 12.38 Million USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Abbott Laboratories | 13.59 Billion USD | 99.817% |
| Allurion Technologies Inc. | 2.3 Million USD | -977.45% |
| Artivion, Inc. | 305.53 Million USD | 91.868% |
| Avanos Medical, Inc. | 159.4 Million USD | 84.413% |
| Butterfly Network, Inc. | 22.83 Million USD | -8.807% |
| Butterfly Network, Inc. | 22.83 Million USD | -8.807% |
| Bio-Rad Laboratories, Inc. | 1.18 Billion USD | 97.911% |
| Boston Scientific Corporation | 8.96 Billion USD | 99.723% |
| CONMED Corporation | 971.48 Million USD | 97.442% |
| Edwards Lifesciences Corporation | 670 Million USD | 96.292% |
| Paragon 28, Inc. | 109.79 Million USD | 77.371% |
| Glaukos Corporation | 383.73 Million USD | 93.525% |
| Globus Medical, Inc. | 417.4 Million USD | 94.047% |
| Integer Holdings Corporation | 959.92 Million USD | 97.412% |
| Medtronic plc | 23.87 Billion USD | 99.896% |
| Myomo, Inc. | 115.16 Thousand USD | -21475.2% |
| Nevro Corp. | 211.47 Million USD | 88.251% |
| Owlet, Inc. | 22 Thousand USD | -112836.364% |
| Penumbra, Inc. | 220.9 Million USD | 88.753% |
| Vicarious Surgical Inc. | 13.78 Million USD | -80.239% |
| Smith & Nephew plc | 2.17 Billion USD | 98.858% |
| Sonendo, Inc. | 14.03 Million USD | -77.029% |
| STERIS plc | 3.12 Billion USD | 99.204% |
| Stryker Corporation | 10.9 Billion USD | 99.772% |
| Vapotherm, Inc. | 109.97 Million USD | 77.408% |
| Zimmer Biomet Holdings, Inc. | 4.86 Billion USD | 99.49% |